The expanding demand for precise immunological study and therapeutic design has spurred significant advances in recombinant growth factor production. IL-1A, IL-1B, IL-2, and IL-3, each possessing unique functional roles, are frequently manufactured using diverse expression systems, including prokaryotic hosts, higher cell lines, and viral transcrip